About AACSB International
AACSB International operates as a non-profit organization of educational institutions, businesses, and other entities devoted to the advancement of management education. The organization offers accreditation, conferences, seminars and webinars, membership, business school data, and management education industry research. It is based in Tampa, Florida.
Missing: AACSB International's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: AACSB International's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest AACSB International News
Nov 29, 2022
Tue Nov 29 02:01:21 UTC 2022 | 25 minuten geledenEconomie Dit is een origineel bericht van PR Newswire Acquisition accelerates Full-Life's transformation into clinical stage radiopharmaceutical company, leveraging its European-focused Radiotechnology and Development Platform BRUSSELS and WATCHUNG, N.J. and SHANGHAI, Nov. 29, 2022 /PRNewswire/ -- Full-Life Technologies, a fully integrated global radiotherapeutics company, today announced an agreement to acquire New Jersey-based Focus-X Therapeutics, a company developing targeted radiopharmaceuticals to treat cancer based on proprietary peptide engineering technology. The acquisition expands Full-Life's pipeline, including two compounds nearing clinical trials, provides a second innovative peptide focused discovery platform, and leverages its Radio Technology manufacturing and logistics platforms to advance compounds into clinical development. Under the terms of the acquisition, Focus-X shareholders are eligible to receive from Full-Life an upfront payment, potential development, regulatory and sales-based milestones of up to $245 million and royalties on any commercial sales. The acquisition is expected to close in the first quarter of 2023. "The Focus-X acquisition perfectly leverages Full-Life's radiotechnology and development platform by adding two development ready compounds, including a lead with initial human data, a robust pipeline and world class peptide discovery capabilities," said Lanny Sun, Co-founder, Chairman and CEO of Full-Life. Fa Liu, PhD, Focus-X's Co-founder and CEO commented, "Full-Life's integrated platforms will provide the manufacturing technology, logistics and clinical development expertise to accelerate development of our compounds as well as expand our discovery efforts. This world class radiopharmaceutical team has enormous potential to develop radiopharmaceutical therapeutics that impact patients worldwide." Founded in 2020, Focus-X has developed a proprietary engineering platform to develop peptide radioligands that precisely deliver alpha or beta emitters to breakdown cancer cell DNA. The platform enables high-quality optimization of peptide radioligand vectors for key pharmaceutical attributes such as biodistribution, binding affinity and in vivo stability. Such optimization can present significant challenges to other ligand targeting compounds such as antibodies. The company has focused on both validated targets and new mechanisms. Focus-X has established a substantial pipeline. The company's two lead compounds in development are a prostate specific membrane antigen (PMSA)-targeted peptide for the treatment of metastatic castration resistant prostate cancer and a neurotensin receptor type 1 (NTSR1)-targeted peptide for the treatment of pancreatic cancer. The PMSA-targeted compound is currently undergoing an investigator-initiated imaging study. Focus-X has six other programs in earlier stages of development. About Full-Life Technologies Full-Life Technologies Limited ("Full-Life") is a fully integrated global radiopharmaceutical company with operations in Europe and China. We seek to own the entire value chain for radiopharmaceutical research & development, production & commercialization in order to deliver clinical impact for patients. The company plans to attack core issues affecting radiopharmaceuticals today through innovative research that targets the treatments of tomorrow. We are comprised of a team of fast-moving entrepreneurs and scientists with a demonstrated track record in the life sciences, as well as radioisotope research and clinical development. Follow us: PR Newswire Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op. Andere persberichten van deze organisatie UCL Computer Science To Explore Natural Language Processing On Quantum Computers For Content Discovery and Archive Retrieval A new consortium funded by the Royal Academy of Engineering will build on work in quantum mechanics and linguistics conducted over 15 years by researchers at University College London and Quantinuum CAMBRIDGE, England, Nov. 28, 2022 /PRNewswire/ -- Quantinuum, the world's leading integrated quantum computing company, has joined a consortium with University College London (UCL) and the British Broadcasting Corporation (BBC) to explore the industri 8 uur geleden CGTN: China, Mongolia inject impetus into ties through three engines BEIJING, Nov. 28, 2022 /PRNewswire/ -- Mongolian President Ukhnaagiin Khurelsuh is paying a state visit to China just two days after the Zuunbayan-Khangi railway, the third railway to connect Mongolia with China, started operations on November 25. Apart from boosting connectivity, the two neighbors joined hands to fight the COVID-19 epidemic by gifting one another with sheep and tea as well as deepened cooperation and exchanges in various fields. 9 uur geleden Tata Communications and Intertec Systems expand partnership, set up Cyber Security Operations Centre in UAE DUBAI, UAE, and SINGAPORE, Nov. 28, 2022 /PRNewswire/ -- Tata Communications International Pte Ltd., a wholly-owned subsidiary of Tata Communications Ltd., a global digital ecosystem enabler has extended its partnership with Intertec Systems, a leading system integrator in the United Arab Emirates (UAE), to offer managed services in the region. As part of the partnership, Tata Communications brings its Cyber Security Operations Centre (SOC) and m 10 uur geleden Hut 8 geeft update over de vestiging in North Bay Dit persbericht vormt een "aangewezen persbericht" in het kader van de aanvulling op de brochure van het bedrijf van 17 augustus 2022 bij de korte basisregistratiebrochure van 5 augustus 2022. TORONTO, 28 november 2022 /PRNewswire/ -- Hut 8 Mining Corp. ("Hut 8" of het "bedrijf") kondigt aan dat het bemiddelingsprocedures heeft verzocht met Validus Power Corp. ("Validus"), een externe leverancier van energie aan de delffaciliteit van het bedrijf 11 uur geleden Carrefour and Danone with Nine Major Food Manufacturers Win 2022 SIRIUS Prize in Sustainable Collaboration for Healthier Lives Initiative in Fran PARIS, Nov. 28, 2022 /PRNewswire/ -- The in-store and digital collaborative initiative "Le Lundi C'est Veggie" "Mondays are Veggie" led through The Consumer Goods Forum's Collaboration for Healthier Lives Coalition of Action (CHL) by Co-Chairs Carrefour and Danone with the engagement of Barilla, Bel, Bonduelle, Fleury Michon, Happyvore, Labeyrie, Nutrition Santé, Savencia and Unilever has won the prestigious SIRIUS Award in Sustainable Collaborat 12 uur geleden AACSB International Announces Retirement of Executive Vice President and Chief Officer of Europe, Middle East, and Africa TAMPA, Fla., Nov. 28, 2022 /PRNewswire/ -- AACSB International (AACSB) announces today that Tim Mescon, executive vice president and chief officer of Europe, the Middle East, and Africa, is retiring on December 31, 2022. Mescon has been part of AACSB since January 2015, when he helped establish and open the AACSB EMEA office in Amsterdam, the Netherlands. "It has been an honor to support AACSB's mission and vision in EMEA--and globally--and to se 12 uur geleden
AACSB International Frequently Asked Questions (FAQ)
When was AACSB International founded?
AACSB International was founded in 1916.
Where is AACSB International's headquarters?
AACSB International's headquarters is located at 777 S Harbour Island Blvd, Tampa.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.